Stephen A. Gorgol
Director of Finance/CFO at BioVex, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Howard Goldsweig | M | - |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | 16 years |
Leonard Post | M | 72 |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | 17 years |
Jean-Sébastien Cleiftie | M | 50 |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | - |
Suzette Dutch | F | - |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | - |
Philippe M. R. Guinot | M | - |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | - |
Lance Weed | M | - |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | 18 years |
Tim Hanke | M | - |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert J. de Vaere | M | 66 |
iVOW, Inc.
iVOW, Inc. Medical/Nursing ServicesHealth Services iVOW Inc, formerly Vista Medical Technologies, Inc. (VMTI) is a disease state management company focused on the treatment of morbid obesity. The company operates two business units: Obesity Surgical and Medical Management Services and Visualization Technology. The Obesity Surgical and Medical Management Services business, operated by the Company's wholly owned subsidiary, VOW Solutions, Inc., provides services to physicians and hospitals involved in the surgical treatment of morbid obesity. Its services include management of the Company's original product offering, the Laparoscopic Bariatric Surgery Preceptorship, an introduction to starting a minimally invasive gastric bypass surgical program. In addition, the business offers consulting and program management services, which enable the efficient operation of obesity surgery programs. | 4 years |
Scott R. Pancoast | M | 58 |
iVOW, Inc.
iVOW, Inc. Medical/Nursing ServicesHealth Services iVOW Inc, formerly Vista Medical Technologies, Inc. (VMTI) is a disease state management company focused on the treatment of morbid obesity. The company operates two business units: Obesity Surgical and Medical Management Services and Visualization Technology. The Obesity Surgical and Medical Management Services business, operated by the Company's wholly owned subsidiary, VOW Solutions, Inc., provides services to physicians and hospitals involved in the surgical treatment of morbid obesity. Its services include management of the Company's original product offering, the Laparoscopic Bariatric Surgery Preceptorship, an introduction to starting a minimally invasive gastric bypass surgical program. In addition, the business offers consulting and program management services, which enable the efficient operation of obesity surgery programs. | 4 years |
John E. Kennedy | M | 66 |
iVOW, Inc.
iVOW, Inc. Medical/Nursing ServicesHealth Services iVOW Inc, formerly Vista Medical Technologies, Inc. (VMTI) is a disease state management company focused on the treatment of morbid obesity. The company operates two business units: Obesity Surgical and Medical Management Services and Visualization Technology. The Obesity Surgical and Medical Management Services business, operated by the Company's wholly owned subsidiary, VOW Solutions, Inc., provides services to physicians and hospitals involved in the surgical treatment of morbid obesity. Its services include management of the Company's original product offering, the Laparoscopic Bariatric Surgery Preceptorship, an introduction to starting a minimally invasive gastric bypass surgical program. In addition, the business offers consulting and program management services, which enable the efficient operation of obesity surgery programs. | 10 years |
Steven Prelack | M | 66 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 2 years |
Philip Astley-Sparke | M | 51 |
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA. | 2 years |
Hugo Slootweg | M | 53 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 8 years |
Kevin Lafond | M | 68 |
Plymouth State University
| 4 years |
Somu Subramaniam | M | 69 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 4 years |
Anne Marie Woodland | F | - |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 4 years |
Claude Cestaro | M | - |
Plymouth State University
| 4 years |
Pamela Esposito | M | 50 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 1 years |
Jonathan W. Hall | M | - |
Plymouth State University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 19 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen A. Gorgol
- Personal Network